Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: S$5.34 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Sanofi SNY	S$10.89 M	S$69.64 M	🇫🇷 France
Biogen BIIB	S$3.4 M	S$75.76 M	🇺🇸 USA
Bristol-Myers Squibb BMY	S$31.05 M	S$81.93 M	🇺🇸 USA
AstraZeneca AZN	S$99.41 M	S$0.16 B	🇬🇧 UK
GSK plc GSK	S$48.95 M	S$0.36 B	🇬🇧 UK
Sangamo Therapeutics SGMO	S$0.39 M	S$8.1 M	🇺🇸 USA
Alnylam Pharmaceuticals ALNY	S$9.93 M	S$38.5 M	🇺🇸 USA